• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为靶向糖蛋白gp120的HIV进入抑制剂的大分子碳水化合物结合剂。

Large-molecular-weight carbohydrate-binding agents as HIV entry inhibitors targeting glycoprotein gp120.

作者信息

Balzarini Jan

机构信息

Rega Institute for Medical Research, B-3000 Leuven, Belgium.

出版信息

Curr Opin HIV AIDS. 2006 Sep;1(5):355-60. doi: 10.1097/01.COH.0000239846.36076.2c.

DOI:10.1097/01.COH.0000239846.36076.2c
PMID:19372833
Abstract

PURPOSE OF REVIEW

Given the continuing expansion of the HIV pandemic, more emphasis on new methods of treatment and prevention of the HIV infection is urgently needed.

RECENT FINDINGS

Several carbohydrate-binding agents, basically monomeric, dimeric or tetrameric proteins (lectins), are endowed with a pronounced anti-HIV activity in cell culture. They inhibit the viral entry (fusion) process and can block HIV infections by cell-free virions, as well as virus cell-cell transmission. Prolonged exposure to carbohydrate-binding agents slowly and progressively selects for deletions of glycans at N-glycosylation sites in HIV gp120. Such mutant virus strains retain full sensitivity to other anti-HIV drugs. Moreover, virus strains that contain deleted glycans in their gp120 envelope may trigger the immune system to produce neutralizing antibodies against the uncovered immunogenic epitopes on HIV gp120, contributing further to the elimination of the mutant virus particles from the bloodstream. Efficient expression of carbohydrate-binding agents by commensal bacteria has been achieved and may be an interesting novel approach to protect the vaginal mucosa against HIV infection/transmission.

SUMMARY

Carbohydrate-binding proteins are a unique group of natural products that may qualify as efficient microbicides and as a potential tool to prevent mother-to-infant virus transmission.

摘要

综述目的

鉴于艾滋病毒大流行的持续蔓延,迫切需要更加重视艾滋病毒感染的新治疗和预防方法。

最新发现

几种碳水化合物结合剂,基本上是单体、二聚体或四聚体蛋白(凝集素),在细胞培养中具有显著的抗艾滋病毒活性。它们抑制病毒进入(融合)过程,可阻断无细胞病毒体的艾滋病毒感染以及病毒的细胞间传播。长时间接触碳水化合物结合剂会缓慢且逐渐地导致艾滋病毒gp120中N - 糖基化位点的聚糖缺失。此类突变病毒株对其他抗艾滋病毒药物仍保持完全敏感性。此外,其gp120包膜中含有缺失聚糖的病毒株可能会触发免疫系统产生针对艾滋病毒gp120上未被覆盖的免疫原性表位的中和抗体,进一步有助于从血液中清除突变病毒颗粒。共生细菌已实现碳水化合物结合剂的高效表达,这可能是保护阴道黏膜免受艾滋病毒感染/传播的一种有趣的新方法。

总结

碳水化合物结合蛋白是一类独特的天然产物,可能成为有效的杀菌剂以及预防母婴病毒传播的潜在工具。

相似文献

1
Large-molecular-weight carbohydrate-binding agents as HIV entry inhibitors targeting glycoprotein gp120.作为靶向糖蛋白gp120的HIV进入抑制剂的大分子碳水化合物结合剂。
Curr Opin HIV AIDS. 2006 Sep;1(5):355-60. doi: 10.1097/01.COH.0000239846.36076.2c.
2
Inhibition of HIV entry by carbohydrate-binding proteins.碳水化合物结合蛋白对HIV进入的抑制作用。
Antiviral Res. 2006 Sep;71(2-3):237-47. doi: 10.1016/j.antiviral.2006.02.004. Epub 2006 Mar 9.
3
Glycan deletions in the HIV-1 gp120 V1/V2 domain compromise viral infectivity, sensitize the mutant virus strains to carbohydrate-binding agents and represent a specific target for therapeutic intervention.HIV-1 gp120 V1/V2结构域中的聚糖缺失会损害病毒感染性,使突变病毒株对碳水化合物结合剂敏感,并成为治疗干预的特定靶点。
Virology. 2008 Dec 5;382(1):10-9. doi: 10.1016/j.virol.2008.09.010. Epub 2008 Oct 19.
4
Simian immunodeficiency virus is susceptible to inhibition by carbohydrate-binding agents in a manner similar to that of HIV: implications for further preclinical drug development.猿猴免疫缺陷病毒与人类免疫缺陷病毒一样,对碳水化合物结合剂的抑制作用敏感:对进一步临床前药物开发的启示。
Mol Pharmacol. 2008 Aug;74(2):330-7. doi: 10.1124/mol.108.047621. Epub 2008 May 12.
5
A conserved molecular action of native and recombinant Epap-1 in inhibition of HIV-1 gp120 mediated viral entry.
Arch Biochem Biophys. 2006 Dec 1;456(1):79-92. doi: 10.1016/j.abb.2006.09.013. Epub 2006 Oct 5.
6
2-deoxy-D-glucose as a potential drug against fusogenic viruses including HIV.2-脱氧-D-葡萄糖作为一种抗包括HIV在内的融合病毒的潜在药物。
Med Hypotheses. 2008;70(4):776-82. doi: 10.1016/j.mehy.2007.08.021. Epub 2007 Oct 24.
7
Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses?碳水化合物结合剂:未来包膜病毒化疗的潜在基石?
Antivir Chem Chemother. 2007;18(1):1-11. doi: 10.1177/095632020701800101.
8
Insights into neutralizing antibodies and HIV envelope.对中和抗体与HIV包膜的见解。
Curr Opin HIV AIDS. 2006 Jul;1(4):301-8. doi: 10.1097/01.COH.0000232345.31156.eb.
9
Microbicides for the prevention of HIV infection in women: an overview of recent trials.用于预防女性感染艾滋病毒的杀微生物剂:近期试验综述
Curr Opin HIV AIDS. 2006 Nov;1(6):514-9. doi: 10.1097/01.COH.0000247386.62743.b4.
10
The caveolin-1 binding domain of HIV-1 glycoprotein gp41 (CBD1) contains several overlapping neutralizing epitopes.HIV-1糖蛋白gp41的小窝蛋白-1结合结构域(CBD1)包含多个重叠的中和表位。
Vaccine. 2009 Jun 2;27(27):3620-30. doi: 10.1016/j.vaccine.2009.03.057. Epub 2009 Apr 10.

引用本文的文献

1
Griffithsin inhibits porcine reproductive and respiratory syndrome virus infection in vitro.格里菲斯素在体外抑制猪繁殖与呼吸综合征病毒感染。
Arch Virol. 2018 Dec;163(12):3317-3325. doi: 10.1007/s00705-018-4029-x. Epub 2018 Sep 15.
2
Is the LysM domain of L. monocytogenes p60 protein suitable for engineering a protein with high peptidoglycan binding affinity?单核细胞增生李斯特菌p60蛋白的溶菌酶(LysM)结构域是否适合用于构建具有高肽聚糖结合亲和力的蛋白质?
Bioengineered. 2016 Nov;7(6):406-410. doi: 10.1080/21655979.2016.1200772. Epub 2016 Jun 22.
3
Antiviral activity of recombinant porcine surfactant protein A against porcine reproductive and respiratory syndrome virus in vitro.
重组猪表面活性蛋白A对猪繁殖与呼吸综合征病毒的体外抗病毒活性
Arch Virol. 2016 Jul;161(7):1883-90. doi: 10.1007/s00705-016-2838-3. Epub 2016 Apr 21.
4
Molecular basis for bacterial peptidoglycan recognition by LysM domains.赖氨酰基(LysM)结构域识别细菌肽聚糖的分子基础。
Nat Commun. 2014 Jun 30;5:4269. doi: 10.1038/ncomms5269.
5
Human rElafin Inhibits HIV-1 Replication in Its Natural Target Cells.人源Relafin抑制HIV-1在其天然靶细胞中的复制。
Biores Open Access. 2013 Apr;2(2):128-37. doi: 10.1089/biores.2012.0275.
6
Plant made anti-HIV microbicides--a field of opportunity.植物源抗 HIV 微生态制剂——一个充满机遇的领域。
Biotechnol Adv. 2012 Nov-Dec;30(6):1614-26. doi: 10.1016/j.biotechadv.2012.06.002. Epub 2012 Jun 28.
7
Activity and safety of synthetic lectins based on benzoboroxole-functionalized polymers for inhibition of HIV entry.基于苯并硼杂环戊烷功能化聚合物的合成凝集素抑制 HIV 进入的活性和安全性。
Mol Pharm. 2011 Dec 5;8(6):2465-75. doi: 10.1021/mp2002957. Epub 2011 Sep 26.
8
Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes.相对于其gp120包膜中存在N-聚糖缺失的1型人类免疫缺陷病毒毒株,氰苷的突变途径、耐药谱及副作用。
J Virol. 2006 Sep;80(17):8411-21. doi: 10.1128/JVI.00369-06.